Bizzozero G.Uber die sclauchformigen drusen des magendarmkanal und die beziehungen ihres epithels zu dem oberflachenepithel der Scheimhaut . Arch Mikrobiol Anat.1893;42:82-152.
2.
Kreinitz W.Uber das aufreten von spirochaeten verschiedener form im mageninhalt bei carcinoma ventriculi. Deutsch Med Wochenschr..1906;32:872-888.
3.
Luger A., Nueberger H.Uber spirochatenbefunde im magensaft und deren diagnostische bedeutung fur das carcinoma ventriculi. Ztschr F Klin Med.1921;92:54-75.
4.
Doenges JLSpirochetes in the gastric glands of Macacus rhesus and of man without related disease. Arch Pathol.1939;27:469-477.
5.
Steer HW, Colin-Jones DGMucosal changes in gastric ulceration and their response to carbenoxolone sodium. Gut. 1975;16:590-597.
6.
Marshall BJ, Warren JRUnidentified curved bacilli in the stomachs of patients with gastritis and peptic ulceration. Lancet. 1984; 1(8390):1311-1315.
7.
Marshall BJ, Armstrong JA, McGeehie DB, et al. Attempts to fulfill Koch's postulates for pyloric Campylobacter . Med J Aust.1985;142:436-439.
8.
Drumm B., Sherman P., Cutz E., Karmali M.Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med. 1987;316:1557-1561.
9.
Kilbridge PM , Dahms BB, Czinn SJCampylobacter pylori -associated gastritis and peptic ulcer disease in children. Am J Dis Child.1988;142:1149-1152.
10.
Glassman MS , Schwarz SM, Medow MS, et al. Campylobacter pylori -related gastrointestinal disease in children: incidence and clinical findings. Dig Dis Sci.1989;34:1501-1504.
11.
Drumm B., O'Brien A., Cutz E., Sherman P.Campylobacter pyloridis -associated primary gastritis in children . Pediatrics. 1987;80:192-195.
12.
Glupczynski Y.Burette A.Drug therapy of Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol.1990; 85:1545-1551.
13.
Lambert JR, Hansky J., Eaves ER, et al. Campylobacter- like organisms in human stomach. Gastroenterology. 1985;88:A1463.
14.
Goodwin CS, Blincow ED, Warren JR, et al. Evaluation of culture techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol.1985;38:1127-1131.
15.
Barbara L., Biasco G., Capurso L., et al. Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients. Am J Gastroenterol.1990;85:1109-1113.
16.
Klein PD, Graham DY, Opekun AR, et al. High prevalence of Campylobacter pylori in poor and rich Peruvian children determined by 13 C-urea breath test. Gastroenterology.1989;96:A260.
17.
Barthel JS, Westblom TU, Harvey AD, et al. Gastritis and Campylobacter pylori in healthy, asymptomatic volunteers. Arch Intern Med.1988;148:1149-1151.
18.
Dooley CP, Fitzgibbons PL, Cohen H., et al. Prevalence and distribution of Campylobacter pylori in an asymptomatic population. Gastroenterology. 1988;94:A102.
19.
Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race and socioeconomic status. Gastroenterology. 1991;100:1495-1501.
20.
Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJCampylobacter pylori antibodies in humans . Ann Intern Med.1988;109:11-17.
21.
Jones DM, Eldridge J., Fox AJ, et al. Antibody to the gastric Campylobacter-like organism ("Campylobacter pyloridis" ) —clinical correlations and distribution in the normal population . J Med Microbiol.1986;22:57-6221.
22.
Fiedorek SC , Malaty HM, Evans DL, et al. Factors influencing the epidemiology of Helicobacter pylori in children. Pediatrics.1991;88:578-582.
23.
Drumm B., Perez-Perez GI, Blaser MJ, Sherman PMIntrafamilial clustering of Helicobacter pylori infection. N Engl J Med.1990;322:359-363.
24.
Vaira D., D'Anastasia C., Helton J., et al. Campylobacter pylori in abattoir workers. Is it a zoonosis?Lancet. 1988;2:725-726.
25.
Rawles JW, Harris ML, Paull G., et al. Antibody to Campylobacter pyloridis in endoscopy personnel, patients and controls. Gastroenterology. 1987 ;92:A1589.
26.
Slomiany BL, Kasinathan C., Slomiany A.Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol). Am J Gastroenterol.1989 ;84:1273-1277.
27.
Rosenthal LE , Mobley Hlt, Cortesia MJ, Smoot D.Characterization of urease from Campylobacter pylori: possible therapeutic role for urease inhibitors. Am J Gastroenterol.1987;92:934-940.
28.
Graham DY, Opekun A., Lew GM, et al. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter ( Campylobacter) pylori infection . Am J Gastroenterol.1990;85:394-398.
29.
Negrini R., Lisato L., Zanella I.Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology. 1991 ;101:437-445.
30.
Raus Eaj, Langenberg W., Houthof HJ, et al. Campylobacter pyloridis -associated chronic active antral gastritis . Gastroenterology. 1988;94:33-40.
31.
Marshall BJ , Goodwin CS, Warren JR, et al. Long-term healing of gastritis and low duodenal ulcer relapse after eradication of Campylobacter pyloridis. A prospective, double-blind study. Gastroenterology . 1987;92:A1518.
32.
Lee FI, Samolff IM, Hardman M.Comparison of tri-potassium di-citrato and bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet . 1985;1(8441):1299-1302.
33.
Cheng EH, Bermanski P., Silversmith M., et al. Prevalence of Campylobacter pylori in esophagitis, gastritis and duodenal disease. Arch Intern Med.1989 ;149:1373-1375.
34.
Coghlan JG, Gilligan D., Humphries H., et al. Campylobacter pylori and recurrence of duodenal ulcer: A 12-month study. Lancet. 1987;2:1109-1111.
35.
Marshall BJ , Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal relapse after eradication of Campylobacter pylori. Lancet. 1988;2:1437-1441.
36.
Ormand JE, Talley NJCampylobacter pylori, mucus and peptic ulceration. J Clin Gastroenterol.1989;11:492-495.
37.
Talley NJ, Cameron AJ, Shorter RG, et al. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc.1988;63:1176-1180.
Glassman MS , Dallal S., Berzin SH, et al. Utility of enzyme-linked immunosorbent assay (ELISA) in the identification of Helicobacter pylori infection in children . Dig Dis Sci.1990;35:993-997.
40.
Oderda G., Vaira D., Helton J.Helicobacter pylori in children with peptic ulcer disease and their families . Dig Dis Sci.1991;36:572-576.
41.
Tolia V., Chang CH, Brennan S., et al. Occurrence and diagnosis of Campylobacter pylori infection in children. Int Pediatr.1990;5:37-41.
42.
Queiroz Dmm , Rocha GA, Mendes EN, et al. Differences in distribution and severity of Helicobacter pylori gastritis in children and adults with duodenal ulcer disease. J Pediatr Gastroenterol Nutr.1991 ;12:178-181.
43.
Hassall E., Dimmick JEUnique features of Helicobacter pylori disease in children. DigDis Sci.1991;36:417-423.
44.
Price AB, Levi J., Dolby JM, et al. Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology and scanning electron microscopy. Gut. 1985;26:1183-1188.
45.
Czinn SJ, Carr HS, Speck WSEffects of topical anaesthetic agents on Campylobacter pylori. J Pediatr Gastroenterol Nutr.1989;9:46-48.
46.
Schnell GA, Schubert TTUsefulness of culture, histology and urease testing in the detection of Campylobacter pylori. Am J Gastroenterol.1989;84:133-137.
47.
Graham DY, Klein PD, Evans DG, et al. Rapid, non-invasive diagnosis of gastric Gampylobacter by a 13 C -urea breath test. Gastroenterology. 1986;19:A1435.
48.
Hui WM, Lam SK, Chau PY, et al. Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci.1987;32:1255-1260.
49.
Ho J., Hui WM, Ng I., Lam SKNatural history of Campylobacter pylori in duodenal ulceration treated with H2 status antagonist. Amiment Pharmacol Ther.1989;3:315-320.
50.
Graham DY, Lew GM, Evans DG, et al. Effect of triple therapy on duodenal ulcer: a randomized controlled trial. Ann Intern Med.1991;115:266-269.
51.
Lanza FL, Skoglund ML, Rack MF, Yardley JHThe effect of bismuth subsalicylate on the histological gastritis seen in Campylobacter pylori: a placebo-controlled study. Am J Gastroenterol.1989;84:1060-1064.
52.
Hui WM, Lam SK, Ho J., et al. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. DigDis Sci.1991;36:577-582.
53.
De Giacomo C, Maggiore G., Licardi G., et al. Effects of antibacterial treatment of Campylobacter pylori -associated gastritis in children. Gastroenterology. 1988;95:1699.
54.
Oderda G., Dell'Olio D, Morra I, Ansaldi N. Campylobacter pylori gastritis: long term results of treatment with amoxycillin. ArchDis Child.1989;64:326-329.
55.
Drumm B., Sherman P., Chiasson D., et al. Treatment of Campylobacter pylori -associated antral gastritis in children with bismuth subsalicylate and ampicillin. J Pediatr.1988;113:908-912.
56.
Oderda G., Holton J., Altare F., et al. Amoxicillin plus tinidazole for Campylobacter pylori gastritis in children. Assessment by serum IgG antibody, pepsinogen I and gastric level . Lancet. 1989;1 (8640):690-692.
57.
De Giacomo C, Fiocca R., Villani L., et al. Helicobacter pylori infection and chronic gastritis: clinical, serological, and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate . J Pediatr Gastroenterol Nutr.1990;11:310-316.